Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 1/2020

Open Access 01-01-2020 | Polymerase Chain Reaction | Head and Neck

Association of regenerating gene 1A single-nucleotide polymorphisms and nasopharyngeal carcinoma susceptibility in southern Chinese population

Authors: Haijie Xing, Xiangdong Chen, Hongxia Sun, Yaofeng Han, Lanshu Ding, Xiaoxia Chen

Published in: European Archives of Oto-Rhino-Laryngology | Issue 1/2020

Login to get access

Abstract

Objective

Nasopharyngeal carcinoma (NPC) is a common malignancy in Southern China and Southeast Asia. Genetic susceptibility is a major contributing factor in determining the individual risk of NPC in these areas. To test the association between NPC and variants in regenerating gene 1A (REG1A), we conducted a hospital-based case–control study in a Cantonese-speaking population from Guangdong province.

Methods

We endeavored to determine whether genetic variants of the REG1A gene were associated with the risk of NPC amidst the Cantonese population in a hospital-based case–control study using polymerase chain reaction-restriction and direct sequencing analysis in 211 NPC patients and 150 healthy controls. The association between NPC risk and the 14C/T, 20C/T, 369G/T, 1201A/G, and 2922C/T polymorphisms was examined after adjustment for age and sex.

Results

We found an increased risk of developing NPC in individuals with REG1A 2922C/T variant genotype (p = 0.003, OR 0.419, 95% CI 0.235–0.746), and after adjustment for sex and age (p = 0.003, OR 0.406, 95% CI 0.226–0.732). No association between other polymorphisms (14C/T, 20C/T, 369G/T, and 1201A/G) and the risk of NPC was observed, before or after adjustment for age and sex.

Conclusion

Our findings suggest that the REG1A 2922C/T polymorphism is associated with an increased risk of developing NPC in a Cantonese population from Guangdong province. Larger studies are required to confirm our findings and unravel the underlying mechanisms.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30CrossRef Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30CrossRef
2.
go back to reference Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S, Endo K (2012) Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx 39(2):137–144CrossRef Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S, Endo K (2012) Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx 39(2):137–144CrossRef
3.
go back to reference Liu Z, Fang F, Chang ET, Ye W (2015) Cancer risk in the relatives of patients with nasopharyngeal carcinoma—a register-based cohort study in Sweden. Br J Cancer 112(11):1827–1831CrossRef Liu Z, Fang F, Chang ET, Ye W (2015) Cancer risk in the relatives of patients with nasopharyngeal carcinoma—a register-based cohort study in Sweden. Br J Cancer 112(11):1827–1831CrossRef
4.
go back to reference Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, Liu MY (1990) Multiple risk factors of nasopharyngeal carcinoma: Epstein–Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 10(2B):547–553PubMed Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, Liu MY (1990) Multiple risk factors of nasopharyngeal carcinoma: Epstein–Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 10(2B):547–553PubMed
5.
go back to reference Schottenfeld D, Fraumeni JF (2006) Cancer epidemiology and prevention. Oxford University Press, OxfordCrossRef Schottenfeld D, Fraumeni JF (2006) Cancer epidemiology and prevention. Oxford University Press, OxfordCrossRef
6.
go back to reference Zeng L, Luo S, Li X, Lu M, Li H, Li T, Wang G, Lyu X, Jia W, Dong Z, Jiang Q, Shen Z, Huang GL, He Z (2017) Functional PIN1 promoter polymorphisms associated with risk of nasopharyngeal carcinoma in Southern Chinese populations. Sci Rep 7(1):4593CrossRef Zeng L, Luo S, Li X, Lu M, Li H, Li T, Wang G, Lyu X, Jia W, Dong Z, Jiang Q, Shen Z, Huang GL, He Z (2017) Functional PIN1 promoter polymorphisms associated with risk of nasopharyngeal carcinoma in Southern Chinese populations. Sci Rep 7(1):4593CrossRef
7.
go back to reference Yang Y, Liu W, Zhao Z, Zhang Y, Xiao H, Luo B (2017) Filaggrin gene polymorphism associated with Epstein–Barr virus-associated tumors in China. Virus Genes 53(4):532–537CrossRef Yang Y, Liu W, Zhao Z, Zhang Y, Xiao H, Luo B (2017) Filaggrin gene polymorphism associated with Epstein–Barr virus-associated tumors in China. Virus Genes 53(4):532–537CrossRef
8.
go back to reference Deng L, Zhao XR, Pan KF, Wang Y, Deng XY, Lü YY, Cao Y (2002) Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34(1):16–20 Deng L, Zhao XR, Pan KF, Wang Y, Deng XY, Lü YY, Cao Y (2002) Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34(1):16–20
9.
go back to reference Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, Levine PH, Liu MY, Chen JY, Brinton LA, Cheng YJ, Yang CS (2003) Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1and hOGG1. Cancer Epidemiol Biomark Prev 12(10):1100–1104 Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, Levine PH, Liu MY, Chen JY, Brinton LA, Cheng YJ, Yang CS (2003) Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1and hOGG1. Cancer Epidemiol Biomark Prev 12(10):1100–1104
10.
go back to reference Guo XB, Ma WL, Liu LJ, Huang YL, Wang J, Huang LH, Peng XD, Yin JY, Li JG, Chen SJ, Yang GP, Wang H, Guo CX (2017) Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinoma. Acta Pharmacol Sin 38(4):571–580CrossRef Guo XB, Ma WL, Liu LJ, Huang YL, Wang J, Huang LH, Peng XD, Yin JY, Li JG, Chen SJ, Yang GP, Wang H, Guo CX (2017) Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinoma. Acta Pharmacol Sin 38(4):571–580CrossRef
11.
go back to reference Guo C, Huang Y, Yu J, Liu L, Gong X, Huang M, Jiang C, Liao Y, Huang L, Yang G, Li J (2017) The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma. Oncotarget 8(15):25334–25344CrossRef Guo C, Huang Y, Yu J, Liu L, Gong X, Huang M, Jiang C, Liao Y, Huang L, Yang G, Li J (2017) The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma. Oncotarget 8(15):25334–25344CrossRef
12.
go back to reference Ma WL, Liu R, Huang LH, Zou C, Huang J, Wang J, Chen SJ, Meng XG, Yang JK, Li H, Yang GP, Guo CX (2017) Impact of polymorphisms in angiogenesis-related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinoma. Clin Exp Pharmacol Physiol 44(5):539–548CrossRef Ma WL, Liu R, Huang LH, Zou C, Huang J, Wang J, Chen SJ, Meng XG, Yang JK, Li H, Yang GP, Guo CX (2017) Impact of polymorphisms in angiogenesis-related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinoma. Clin Exp Pharmacol Physiol 44(5):539–548CrossRef
13.
go back to reference Tan J, Jiang L, Cheng X, Wang C, Chen J, Huang X, Xie P, Xia D, Wang R, Zhang Y (2017) Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Onco Targets Ther 10(2):909–918CrossRef Tan J, Jiang L, Cheng X, Wang C, Chen J, Huang X, Xie P, Xia D, Wang R, Zhang Y (2017) Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Onco Targets Ther 10(2):909–918CrossRef
14.
go back to reference Tse KP, Tsang NM, Chen KD, Li HP, Liang Y, Hsueh C, Chang KP, Yu JS, Hao SP, Hsieh LL, Chang YS (2007) MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin Cancer Res 13(21):6320–6326CrossRef Tse KP, Tsang NM, Chen KD, Li HP, Liang Y, Hsueh C, Chang KP, Yu JS, Hao SP, Hsieh LL, Chang YS (2007) MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin Cancer Res 13(21):6320–6326CrossRef
15.
go back to reference Ghandri N, Gabbouj S, Farhat K, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L, Hassen E (2011) Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome. Hum Immunol 72(2):150–158CrossRef Ghandri N, Gabbouj S, Farhat K, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L, Hassen E (2011) Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome. Hum Immunol 72(2):150–158CrossRef
16.
go back to reference Zhang YW, Ding LS, Lai MD (2003) Reg gene family and human diseases. World J Gastroenterol 9(12):2635–2641CrossRef Zhang YW, Ding LS, Lai MD (2003) Reg gene family and human diseases. World J Gastroenterol 9(12):2635–2641CrossRef
17.
go back to reference Carrere J, Guy-Crotte O, Gaia E, Figarella C (1999) Immunoreactive pancreatic Reg protein insera from cystic fibrosis patients with and without pancreatic in sufficiency. Gut 44(4):545–551CrossRef Carrere J, Guy-Crotte O, Gaia E, Figarella C (1999) Immunoreactive pancreatic Reg protein insera from cystic fibrosis patients with and without pancreatic in sufficiency. Gut 44(4):545–551CrossRef
18.
go back to reference Fukui H, Fujii S, Takeda J, Kayahara T, Sekikawa A, Nanakin A, Suzuki K, Hisatsune H, Seno H, Sawada M, Fujimori T, Chiba T (2004) Expression of RegIa protein in human gastric cancers. Digestion 69(3):177–184CrossRef Fukui H, Fujii S, Takeda J, Kayahara T, Sekikawa A, Nanakin A, Suzuki K, Hisatsune H, Seno H, Sawada M, Fujimori T, Chiba T (2004) Expression of RegIa protein in human gastric cancers. Digestion 69(3):177–184CrossRef
19.
go back to reference Rechreche H, Montalto G, Mallo GV, Vasseur S, Marasa L, Soubeyran P, Dagorn JC, Iovanna JL (1999) pap, regIa and regIb mRNAs are concomitantly up-regulated during human colorectal carcinogenesis. Int J Cancer 81(5):688–694CrossRef Rechreche H, Montalto G, Mallo GV, Vasseur S, Marasa L, Soubeyran P, Dagorn JC, Iovanna JL (1999) pap, regIa and regIb mRNAs are concomitantly up-regulated during human colorectal carcinogenesis. Int J Cancer 81(5):688–694CrossRef
20.
go back to reference Zhou L, Zhang R, Wang L, Shen S, Okamoto H, Sugawara A, Xia L, Wang X, Noguchi N, Yoshikawa T, Uruno A, Yao W, Yuan Y (2010) Upregulation of REG I alpha accelerates tumor progression in pancreatic cancer with diabetes. Int J Cancer 127(8):1795–1803CrossRef Zhou L, Zhang R, Wang L, Shen S, Okamoto H, Sugawara A, Xia L, Wang X, Noguchi N, Yoshikawa T, Uruno A, Yao W, Yuan Y (2010) Upregulation of REG I alpha accelerates tumor progression in pancreatic cancer with diabetes. Int J Cancer 127(8):1795–1803CrossRef
21.
go back to reference Sasaki Y, Minamiya Y, Takahashi N, Nakagawa T, Katayose Y, Ito A, Saito H, Motoyama S, Ogawa J (2008) REG1A expression is an independent factor predictive of poor prognosis in patients with breast cancer. Ann Surg Oncol 15(11):3244–3251CrossRef Sasaki Y, Minamiya Y, Takahashi N, Nakagawa T, Katayose Y, Ito A, Saito H, Motoyama S, Ogawa J (2008) REG1A expression is an independent factor predictive of poor prognosis in patients with breast cancer. Ann Surg Oncol 15(11):3244–3251CrossRef
22.
go back to reference Minamiya Y, Kawai H, Saito H, Ito M, Hosono Y, Motoyama S, Katayose Y, Takahashi N, Ogawa J (2008) REG1A expression is an independent factor predictive of poor prognosis in patients with non-small cell lung cancer. Lung Cancer 60(1):98–104CrossRef Minamiya Y, Kawai H, Saito H, Ito M, Hosono Y, Motoyama S, Katayose Y, Takahashi N, Ogawa J (2008) REG1A expression is an independent factor predictive of poor prognosis in patients with non-small cell lung cancer. Lung Cancer 60(1):98–104CrossRef
23.
go back to reference Geng J, Fan J, Wang P, Fang ZJ, Xia GW, Jiang HW, Chen G, Ding Q (2009) REG1A predicts recurrence in stage Ta/T1 bladder cancer. Eur J Surg Oncol 35(8):852–857CrossRef Geng J, Fan J, Wang P, Fang ZJ, Xia GW, Jiang HW, Chen G, Ding Q (2009) REG1A predicts recurrence in stage Ta/T1 bladder cancer. Eur J Surg Oncol 35(8):852–857CrossRef
24.
go back to reference Yuan RH, Jeng YM, Chen HL, Hsieh FJ, Yang CY, Lee PH, Hsu HC (2005) Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis. Clin Cancer Res 11(7):2568–2575CrossRef Yuan RH, Jeng YM, Chen HL, Hsieh FJ, Yang CY, Lee PH, Hsu HC (2005) Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis. Clin Cancer Res 11(7):2568–2575CrossRef
25.
go back to reference Aboshanif M, Kawasaki Y, Omori Y, Suzuki S, Honda K, Motoyama S, Ishikawa K (2016) Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma. Diagn Pathol 11(1):79CrossRef Aboshanif M, Kawasaki Y, Omori Y, Suzuki S, Honda K, Motoyama S, Ishikawa K (2016) Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma. Diagn Pathol 11(1):79CrossRef
26.
go back to reference Hayashi K, Motoyama S, Sugiyama T, Izumi J, Anbai A, Nanjo H, Watanabe H, Maruyama K, Minamiya Y, Koyota S, Koizumi Y, Takasawa S, Murata K, Ogawa J (2008) REGIalpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients. Ann Surg Oncol 15(4):1224–1231CrossRef Hayashi K, Motoyama S, Sugiyama T, Izumi J, Anbai A, Nanjo H, Watanabe H, Maruyama K, Minamiya Y, Koyota S, Koizumi Y, Takasawa S, Murata K, Ogawa J (2008) REGIalpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients. Ann Surg Oncol 15(4):1224–1231CrossRef
28.
go back to reference Hawrami K, Mohan V, Bone A, Hitman GA (1997) Analysis of islet regenerating (reg) gene polymorphisms in fibrocalculous pancreatic diabetes. Pancreas 14(2):122–125CrossRef Hawrami K, Mohan V, Bone A, Hitman GA (1997) Analysis of islet regenerating (reg) gene polymorphisms in fibrocalculous pancreatic diabetes. Pancreas 14(2):122–125CrossRef
29.
go back to reference Mahurkar S, Bhaskar S, Reddy DN, Rao GV, Chandak GR (2007) Comprehensive screening for reg1alpha gene rules out association with tropical calcific pancreatitis. World J Gastroenterol 13(44):5938–5943CrossRef Mahurkar S, Bhaskar S, Reddy DN, Rao GV, Chandak GR (2007) Comprehensive screening for reg1alpha gene rules out association with tropical calcific pancreatitis. World J Gastroenterol 13(44):5938–5943CrossRef
30.
go back to reference Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA net-works: the implications for cancer research. Nat Rev Cancer 10(6):389–402CrossRef Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA net-works: the implications for cancer research. Nat Rev Cancer 10(6):389–402CrossRef
Metadata
Title
Association of regenerating gene 1A single-nucleotide polymorphisms and nasopharyngeal carcinoma susceptibility in southern Chinese population
Authors
Haijie Xing
Xiangdong Chen
Hongxia Sun
Yaofeng Han
Lanshu Ding
Xiaoxia Chen
Publication date
01-01-2020
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 1/2020
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-019-05645-9

Other articles of this Issue 1/2020

European Archives of Oto-Rhino-Laryngology 1/2020 Go to the issue